Terms: = Germ cell tumor AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Prognosis
8560 results:
1. Prognostic nomogram in middle-aged and elderly patients with chordoma: A SEER-based study.
Ouyang C; Sun Y; Li Y; Jiang M; Nong L; Gao G
J Orthop Surg (Hong Kong); 2024; 32(2):10225536241254208. PubMed ID: 38744697
[TBL] [Abstract] [Full Text] [Related]
2. EGCG Disrupts the LIN28B/Let-7 Interaction and Reduces Neuroblastoma Aggressiveness.
Cocchi S; Greco V; Sidarovich V; Vigna J; Broso F; Corallo D; Zasso J; Re A; Rosatti EF; Longhi S; Defant A; Ladu F; Sanna V; Adami V; D'Agostino VG; Sturlese M; Sechi M; Aveic S; Mancini I; Sighel D; Quattrone A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732012
[TBL] [Abstract] [Full Text] [Related]
3. CDCA3 is a potential biomarker for glioma malignancy and targeted therapy.
Han C; Liu S; Ji Y; Hu Y; Zhang J
Medicine (Baltimore); 2024 May; 103(19):e38066. PubMed ID: 38728485
[TBL] [Abstract] [Full Text] [Related]
4. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract] [Full Text] [Related]
5. Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis.
Zeng F; Guo P; Xia M; He M
J Cancer Res Clin Oncol; 2024 May; 150(5):236. PubMed ID: 38710946
[TBL] [Abstract] [Full Text] [Related]
6. Metastatic Merkel cell Carcinoma After Simultaneous Pancreas-Kidney Transplantation: Fatal Outcomes.
Burke O; Labib A; Burke G; Beer J; Nichols A
J Drugs Dermatol; 2024 May; 23(5):376-379. PubMed ID: 38709686
[TBL] [Abstract] [Full Text] [Related]
7. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
Zhan Z; Lin K; Wang T
BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
[TBL] [Abstract] [Full Text] [Related]
8. A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy.
Huang R; Lu X; Sun X; Wu H
Int J Immunopathol Pharmacol; 2024; 38():3946320241249395. PubMed ID: 38687369
[No Abstract] [Full Text] [Related]
9. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
[TBL] [Abstract] [Full Text] [Related]
10. germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
11. Two-headed UNetEfficientNets for parallel execution of segmentation and classification of brain tumors: incorporating postprocessing techniques with connected component labelling.
Rai HM; Yoo J; Dashkevych S
J Cancer Res Clin Oncol; 2024 Apr; 150(4):220. PubMed ID: 38684578
[TBL] [Abstract] [Full Text] [Related]
12. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
[TBL] [Abstract] [Full Text] [Related]
13. D-Loop Mutations as Prognostic Markers in Glioblastoma-A Pilot Study.
Szmyd B; Stanisławska P; Podstawka M; Zaczkowski K; Izbiński PM; Kulczycka-Wojdala D; Stawski R; Wiśniewski K; Janczar K; Braun M; Białasiewicz P; Jaskólski DJ; Bobeff EJ
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673919
[TBL] [Abstract] [Full Text] [Related]
14. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma.
Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B
Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429
[TBL] [Abstract] [Full Text] [Related]
15. Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management.
Criss CR; Makary MS
Curr Oncol; 2024 Apr; 31(4):2076-2091. PubMed ID: 38668057
[TBL] [Abstract] [Full Text] [Related]
16. Clinical Presentation, Management, and Diagnostic Performance of 2021 Criteria for Paraneoplastic Neurologic Syndromes in Childhood.
Zhou J; Jin M; Su Y; Zhuo X; Fu L; Ren X; Ren C; Zhou A; Li J; Zhang W
Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200242. PubMed ID: 38657195
[TBL] [Abstract] [Full Text] [Related]
17. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
[TBL] [Abstract] [Full Text] [Related]
18. Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.
Okamoto T; Mizuta R; Takahashi Y; Otani Y; Sasaki E; Horio Y; Kuroda H; Matsushita H; Date I; Hashimoto N; Masago K
J Neurooncol; 2024 May; 167(3):489-499. PubMed ID: 38653957
[TBL] [Abstract] [Full Text] [Related]
19. Melanoma epidemiology in Europe: what is new?
Nurla LA; Forsea AM
Ital J Dermatol Venerol; 2024 Apr; 159(2):128-134. PubMed ID: 38650494
[TBL] [Abstract] [Full Text] [Related]
20. Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study.
Liu C; Kuang S; Huang T; Wu J; Zhang L; Gong X
CNS Neurosci Ther; 2024 Apr; 30(4):e14730. PubMed ID: 38644565
[TBL] [Abstract] [Full Text] [Related]
[Next]